CY1111527T1 - Φαρμακευτικες ενωσεις που περιεχουν μονοκλωνο ιδιοτυπικο anti-ca-125 αντισωμα και αλουμινιο - Google Patents

Φαρμακευτικες ενωσεις που περιεχουν μονοκλωνο ιδιοτυπικο anti-ca-125 αντισωμα και αλουμινιο

Info

Publication number
CY1111527T1
CY1111527T1 CY20111100507T CY111100507T CY1111527T1 CY 1111527 T1 CY1111527 T1 CY 1111527T1 CY 20111100507 T CY20111100507 T CY 20111100507T CY 111100507 T CY111100507 T CY 111100507T CY 1111527 T1 CY1111527 T1 CY 1111527T1
Authority
CY
Cyprus
Prior art keywords
aluminum
antibody
compounds containing
specific anti
pharmaceutical compounds
Prior art date
Application number
CY20111100507T
Other languages
English (en)
Inventor
Jens Flemming
Karsten Gröger
Reinhard Schmitz
Stefano Manzini
Original Assignee
Menarini International Operations Luxembourg S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operations Luxembourg S.A. filed Critical Menarini International Operations Luxembourg S.A.
Publication of CY1111527T1 publication Critical patent/CY1111527T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μια φαρμακευτική σύνθεση για παρεντερική χορήγηση ως εμβόλιο που περιέχει ένα μονόκλωνο αντίσωμα και ως πρόσθετο στοιχείο ένα παράγωγο αλουμινίου
CY20111100507T 2006-06-29 2011-05-23 Φαρμακευτικες ενωσεις που περιεχουν μονοκλωνο ιδιοτυπικο anti-ca-125 αντισωμα και αλουμινιο CY1111527T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000163A ITFI20060163A1 (it) 2006-06-29 2006-06-29 Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
EP07765694A EP2040749B1 (en) 2006-06-29 2007-06-28 Pharmaceutical compositions containing monoclonal anti idiotypic anti-ca-125 antibody and aluminium

Publications (1)

Publication Number Publication Date
CY1111527T1 true CY1111527T1 (el) 2015-08-05

Family

ID=37439367

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100507T CY1111527T1 (el) 2006-06-29 2011-05-23 Φαρμακευτικες ενωσεις που περιεχουν μονοκλωνο ιδιοτυπικο anti-ca-125 αντισωμα και αλουμινιο

Country Status (35)

Country Link
US (2) US20100040625A1 (el)
EP (2) EP2040749B1 (el)
JP (1) JP2009541448A (el)
KR (1) KR20090024240A (el)
CN (1) CN101478987A (el)
AP (1) AP2009004741A0 (el)
AR (1) AR061364A1 (el)
AT (1) ATE502649T1 (el)
AU (1) AU2007263690A1 (el)
BR (1) BRPI0713343A2 (el)
CA (1) CA2655733A1 (el)
CL (1) CL2007001888A1 (el)
CR (1) CR10589A (el)
CY (1) CY1111527T1 (el)
DE (1) DE602007013402D1 (el)
DK (1) DK2040749T3 (el)
EA (1) EA015543B1 (el)
EC (1) ECSP099089A (el)
ES (1) ES2363616T3 (el)
HK (1) HK1126417A1 (el)
HR (1) HRP20110413T1 (el)
IL (1) IL196148A0 (el)
IT (1) ITFI20060163A1 (el)
MA (1) MA30691B1 (el)
MX (1) MX2008016059A (el)
NO (1) NO20090395L (el)
PE (1) PE20080269A1 (el)
PL (1) PL2040749T3 (el)
PT (1) PT2040749E (el)
RS (1) RS51683B (el)
SI (1) SI2040749T1 (el)
TN (1) TNSN08485A1 (el)
UA (1) UA95806C2 (el)
WO (1) WO2008000789A2 (el)
ZA (1) ZA200900563B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
AU2012250924B2 (en) 2011-05-02 2017-05-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
CN110352201A (zh) 2017-04-03 2019-10-18 免疫医疗公司 用于癌症疗法的抗体药物缀合物的皮下施用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5127731B1 (el) * 1971-05-12 1976-08-14
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
CA2163868C (en) 1993-05-27 2008-01-08 Uwe Wagner Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
GB9808485D0 (en) * 1998-04-21 1998-06-17 Univ Cambridge Tech Improvements relating to immunotherapy
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio

Also Published As

Publication number Publication date
ECSP099089A (es) 2009-02-27
KR20090024240A (ko) 2009-03-06
US20090104184A1 (en) 2009-04-23
BRPI0713343A2 (pt) 2012-03-13
AR061364A1 (es) 2008-08-20
RS51683B (en) 2011-10-31
ITFI20060163A1 (it) 2006-09-28
EP2228073A1 (en) 2010-09-15
CR10589A (es) 2009-03-30
TNSN08485A1 (en) 2010-04-14
HK1126417A1 (en) 2009-09-04
EA200900085A1 (ru) 2009-06-30
PT2040749E (pt) 2011-06-30
EP2040749A2 (en) 2009-04-01
WO2008000789A2 (en) 2008-01-03
ES2363616T3 (es) 2011-08-10
EA015543B1 (ru) 2011-08-30
CL2007001888A1 (es) 2008-04-18
MX2008016059A (es) 2009-01-15
ZA200900563B (en) 2010-03-31
DK2040749T3 (da) 2011-06-14
EP2040749B1 (en) 2011-03-23
SI2040749T1 (sl) 2011-06-30
ATE502649T1 (de) 2011-04-15
DE602007013402D1 (de) 2011-05-05
PL2040749T3 (pl) 2011-09-30
NO20090395L (no) 2009-01-27
IL196148A0 (en) 2011-08-01
HRP20110413T1 (hr) 2011-07-31
AP2009004741A0 (en) 2009-02-28
CN101478987A (zh) 2009-07-08
JP2009541448A (ja) 2009-11-26
UA95806C2 (ru) 2011-09-12
PE20080269A1 (es) 2008-05-09
AU2007263690A1 (en) 2008-01-03
MA30691B1 (fr) 2009-09-01
CA2655733A1 (en) 2008-01-03
WO2008000789A3 (en) 2008-02-28
US20100040625A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
CY1117331T1 (el) Αντισωματα προσδεσης στην εξωκυτταρικη περιοχη 4 του ανθρωπινου csf1r και η χρηση αυτων
CY1117563T1 (el) Αντισωματα κατα her3 και χρησεις αυτων
CL2010001426A1 (es) Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas.
LTC2152290I2 (lt) Anti-il-5 antikūnų skyrimo būdai
CY1115091T1 (el) Διειδικες πρωτεϊνες προσδεσης αντιγονων
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CY1115639T1 (el) Διειδικα αγωνιστικα αντισωματα υποδοχεα θανατου
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
BR112017019300A2 (pt) conjugado de fórmula genérica ama - l - x - s - ab, método para sintetizar um conjugado de fórmula genérica ama - l - x - s - ab, kit, método para sintetizar o composto ama - l - x', composição farmacêutica e método para tratar uma doença associada a células que apresentam um alvo
CY1117363T1 (el) Σκευασμα αντισωματος κατα abeta
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
CY1115994T1 (el) Φαρμακευτικες τυποποιησεις οι οποιες περιεχουν προσδεματα υποδοχεα ντοπαμινης
DK2066695T3 (da) Anti-myostatin-antistoffer
ECSP10010722A (es) Compuestos orgánicos
CY1111896T1 (el) Απαραβιαστες φαρμακευτικες μορφες δοσολογιας δια του στοματος περιλαμβανουσες ενα οπιουχο αναλγητικο
BR112012023015A2 (pt) imunoensaios para lenalidomida e talidomida
ATE552276T1 (de) Modifizierter anti-cd52-antikörper
UA118332C2 (uk) Білок, що зв'язує антиген cd27l
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
DK2254549T4 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser
CR10561A (es) Vacunas para malaria
BRPI0814111A2 (pt) Anticorpo monoclonal citotóxico anticâncer
CY2018021I2 (el) Αντισωμα anti-fgf23 και φαρμακευτικη συνθεση που το περιλαμβανει
CY1111527T1 (el) Φαρμακευτικες ενωσεις που περιεχουν μονοκλωνο ιδιοτυπικο anti-ca-125 αντισωμα και αλουμινιο
CY1113435T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγο πυραζινης, και μεθοδος χρησης παραγωγου πυραζινης σε συνδυασμο